The Solomon Center for Health Law and Policy welcomes you to join us for our first event of the year! This panel invites experts and change-makers from various backgrounds to discuss the therapeutic potential of psychedelics, and how to utilize collective action and coalition building to move access and innovation in the field forward.
Featuring:
- Ismail Lourido Ali, J.D. (he/they), Director and Counsel for Policy & Advocacy, Multidisciplinary Association for Psychedelic Studies (MAPS)
- Congressman Earl Blumenauer (he/him), U.S. Representative for Oregon's 3rd Congressional District
- Sharmin Ghaznavi, M.D., Ph.D. (she/her), Associate Director and Director of Cognitive Neuroscience, Center for the Neuroscience of Psychedelics
- Melissa Lavasani, Founder and Executive Director, Psychedelic Medicine Coalition
- Moderator: Mason Marks, M.D., J.D. (he/him), Senior Fellow and Project Lead on the Project on Psychedelics Law and Regulation, Petrie-Flom Center at Harvard Law School
Registration Required!
Sponsoring Organization(s)
Solomon Center for Health Law and Policy
Yale Program for Psychedelic Medicine
Yale Pyschedelic Science Group
The Petrie-Flom Center at Harvard Law School